Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al
Commonly researched for: A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors, currently in advanced clinical trials for obesity and metabolic disorders
That little sign means that an extra electron has been added
It comes in 0.5 mg, 1 mg, or 2 mg doses
We review your medical history, current medications, and goals, and we only prescribe semaglutide when it is appropriate for you
US$ 21.71
US$ 29.38
US$ 24.28
